Search research articles
Contact Us
Filters
Showing results (191-200 of 202) with videos related to
Page
of 21
Sort By:
Journal of Lipid Research
|
April 6, 2001
Identification of platelet-activating factor as the inflammatory lipid mediator in CCl4-metabolizing rat liver
G K Marathe, K A Harrison, L J Roberts, et al.
Neurology
|
February 20, 1999
Increased CSF F2-isoprostane concentration in probable AD
T J Montine, M F Beal, M E Cudkowicz, et al.
Journal of Molecular and Cellular Cardiology
|
December 8, 2009
Selective gamma-ketoaldehyde scavengers protect Nav1.5 from oxidant-induced inactivation
T Nakajima, S S Davies, E Matafonova, et al.
Analytical Biochemistry
|
May 1, 1999
Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay
J D Morrow, W E Zackert, J P Yang, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
July 13, 2001
2,3-Dinor-5,6-dihydro-15-F(2t)-isoprostane: a bioactive prostanoid metabolite
X Hou, L J Roberts, D F Taber, et al.
JAMA
|
August 4, 1999
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study
J L Mills, R DerSimonian, E Raymond, et al.
Biochemistry
|
June 8, 2001
Characterization of the lysyl adducts of prostaglandin H-synthases that are derived from oxygenation of arachidonic acid
O Boutaud, C J Brame, P Chaurand, et al.
Conservation Physiology
|
December 15, 2025
Hair growth rate estimation in North American ursids
Jennifer H Stern, Karyn D Rode, Craig A Stricker, et al.
The Journal of Biological Chemistry
|
November 21, 1998
A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure
K P Moore, S G Holt, R P Patel, et al.
Cancer Chemotherapy and Pharmacology
|
February 6, 2013
Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial
J L Welsh, B A Wagner, T J van't Erve, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 202) with videos related to
Sort By:
Page
of 21
Journal of Lipid Research
|
April 6, 2001
Identification of platelet-activating factor as the inflammatory lipid mediator in CCl4-metabolizing rat liver
G K Marathe, K A Harrison, L J Roberts, et al.
Neurology
|
February 20, 1999
Increased CSF F2-isoprostane concentration in probable AD
T J Montine, M F Beal, M E Cudkowicz, et al.
Journal of Molecular and Cellular Cardiology
|
December 8, 2009
Selective gamma-ketoaldehyde scavengers protect Nav1.5 from oxidant-induced inactivation
T Nakajima, S S Davies, E Matafonova, et al.
Analytical Biochemistry
|
May 1, 1999
Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay
J D Morrow, W E Zackert, J P Yang, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
July 13, 2001
2,3-Dinor-5,6-dihydro-15-F(2t)-isoprostane: a bioactive prostanoid metabolite
X Hou, L J Roberts, D F Taber, et al.
JAMA
|
August 4, 1999
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study
J L Mills, R DerSimonian, E Raymond, et al.
Biochemistry
|
June 8, 2001
Characterization of the lysyl adducts of prostaglandin H-synthases that are derived from oxygenation of arachidonic acid
O Boutaud, C J Brame, P Chaurand, et al.
Conservation Physiology
|
December 15, 2025
Hair growth rate estimation in North American ursids
Jennifer H Stern, Karyn D Rode, Craig A Stricker, et al.
The Journal of Biological Chemistry
|
November 21, 1998
A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure
K P Moore, S G Holt, R P Patel, et al.
Cancer Chemotherapy and Pharmacology
|
February 6, 2013
Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial
J L Welsh, B A Wagner, T J van't Erve, et al.
Page
of 21